Beyond Inhibition: The Strategic Frontier of Targeted Protein Degradation in Early Drug Discovery
In the rapidly evolving landscape of modern pharmacology, we are witnessing a fundamental shift from “blocking” to “destroying.” For decades, the pharmaceutical industry relied on the occupancy-driven model—small molecules designed to sitRead More…
